Literature DB >> 19837867

Genetic regulation of pituitary gland development in human and mouse.

Daniel Kelberman1, Karine Rizzoti, Robin Lovell-Badge, Iain C A F Robinson, Mehul T Dattani.   

Abstract

Normal hypothalamopituitary development is closely related to that of the forebrain and is dependent upon a complex genetic cascade of transcription factors and signaling molecules that may be either intrinsic or extrinsic to the developing Rathke's pouch. These factors dictate organ commitment, cell differentiation, and cell proliferation within the anterior pituitary. Abnormalities in these processes are associated with congenital hypopituitarism, a spectrum of disorders that includes syndromic disorders such as septo-optic dysplasia, combined pituitary hormone deficiencies, and isolated hormone deficiencies, of which the commonest is GH deficiency. The highly variable clinical phenotypes can now in part be explained due to research performed over the last 20 yr, based mainly on naturally occurring and transgenic animal models. Mutations in genes encoding both signaling molecules and transcription factors have been implicated in the etiology of hypopituitarism, with or without other syndromic features, in mice and humans. To date, mutations in known genes account for a small proportion of cases of hypopituitarism in humans. However, these mutations have led to a greater understanding of the genetic interactions that lead to normal pituitary development. This review attempts to describe the complexity of pituitary development in the rodent, with particular emphasis on those factors that, when mutated, are associated with hypopituitarism in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837867      PMCID: PMC2806371          DOI: 10.1210/er.2009-0008

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  316 in total

1.  Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.

Authors:  D C Ambrosetti; C Basilico; L Dailey
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  SOX2 mutation causes anophthalmia, hearing loss, and brain anomalies.

Authors:  Stephanie A Hagstrom; Gayle J T Pauer; Janet Reid; Ellen Simpson; Sue Crowe; Irene H Maumenee; Elias I Traboulsi
Journal:  Am J Med Genet A       Date:  2005-10-01       Impact factor: 2.802

3.  Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene.

Authors:  B B Mendonca; M G Osorio; A C Latronico; V Estefan; L S Lo; I J Arnhold
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

4.  Reduced expression of the LIM-homeobox gene Lhx3 impairs growth and differentiation of Rathke's pouch and increases cell apoptosis during mouse pituitary development.

Authors:  Yangu Zhao; Donna Chelle Morales; Edit Hermesz; Woon-Kyu Lee; Samuel L Pfaff; Heiner Westphal
Journal:  Mech Dev       Date:  2006-06-14       Impact factor: 1.882

5.  The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency.

Authors:  F de Zegher; F Pernasetti; C Vanhole; H Devlieger; G Van den Berghe; J A Martial
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

6.  Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism.

Authors:  M W Sornson; W Wu; J S Dasen; S E Flynn; D J Norman; S M O'Connell; I Gukovsky; C Carrière; A K Ryan; A P Miller; L Zuo; A S Gleiberman; B Andersen; W G Beamer; M G Rosenfeld
Journal:  Nature       Date:  1996-11-28       Impact factor: 49.962

7.  Implementing the LIM code: the structural basis for cell type-specific assembly of LIM-homeodomain complexes.

Authors:  Mugdha Bhati; Christopher Lee; Amy L Nancarrow; Mihwa Lee; Vanessa J Craig; Ingolf Bach; J Mitchell Guss; Joel P Mackay; Jacqueline M Matthews
Journal:  EMBO J       Date:  2008-06-26       Impact factor: 11.598

8.  Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-->Cys at codon 120 (R120C).

Authors:  C Flück; J Deladoey; K Rutishauser; A Eblé; U Marti; W Wu; P E Mullis
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

9.  Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.

Authors:  Alka Mansukhani; Davide Ambrosetti; Greg Holmes; Lizbeth Cornivelli; Claudio Basilico
Journal:  J Cell Biol       Date:  2005-03-21       Impact factor: 10.539

10.  DNMT1 interacts with the developmental transcriptional repressor HESX1.

Authors:  Ezat Sajedi; Carles Gaston-Massuet; Cynthia L Andoniadou; Massimo Signore; Paul J Hurd; Mehul Dattani; Juan Pedro Martinez-Barbera
Journal:  Biochim Biophys Acta       Date:  2007-09-07
View more
  127 in total

1.  Regenerative Medicine: Organ recital in a dish.

Authors:  Karine Rizzoti; Robin Lovell-Badge
Journal:  Nature       Date:  2011-11-30       Impact factor: 49.962

2.  Research resource: A genome-wide study identifies potential new target genes for POU1F1.

Authors:  Jean-Paul Herman; Nicolas Jullien; Séverine Guillen; Alain Enjalbert; Isabelle Pellegrini; Jean-Louis Franc
Journal:  Mol Endocrinol       Date:  2012-05-25

Review 3.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

4.  HESX1- and TCF3-mediated repression of Wnt/β-catenin targets is required for normal development of the anterior forebrain.

Authors:  Cynthia L Andoniadou; Massimo Signore; Rodrigo M Young; Carles Gaston-Massuet; Stephen W Wilson; Elaine Fuchs; Juan Pedro Martinez-Barbera
Journal:  Development       Date:  2011-10-17       Impact factor: 6.868

5.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

6.  Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.

Authors:  Taneli Raivio; Magdalena Avbelj; Mark J McCabe; Christopher J Romero; Andrew A Dwyer; Johanna Tommiska; Gerasimos P Sykiotis; Louise C Gregory; Daniel Diaczok; Vaitsa Tziaferi; Mariet W Elting; Raja Padidela; Lacey Plummer; Cecilia Martin; Bihua Feng; Chengkang Zhang; Qun-Yong Zhou; Huaibin Chen; Moosa Mohammadi; Richard Quinton; Yisrael Sidis; Sally Radovick; Mehul T Dattani; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

Review 7.  Pituitary stem cell update and potential implications for treating hypopituitarism.

Authors:  Frederic Castinetti; Shannon W Davis; Thierry Brue; Sally A Camper
Journal:  Endocr Rev       Date:  2011-04-14       Impact factor: 19.871

Review 8.  Signaling and Gene Regulatory Networks in Mammalian Lens Development.

Authors:  Ales Cvekl; Xin Zhang
Journal:  Trends Genet       Date:  2017-08-31       Impact factor: 11.639

Review 9.  The genetic basis of female reproductive disorders: etiology and clinical testing.

Authors:  Lawrence C Layman
Journal:  Mol Cell Endocrinol       Date:  2013-03-14       Impact factor: 4.102

Review 10.  The molecular basis of craniofacial placode development.

Authors:  Sunita Singh; Andrew K Groves
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-03-07       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.